Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Retinal Pigment Epithelium (RPE) Atrophy”

12 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 12 of 12 results

Not applicableUnknownNCT06306690
What this trial is testing

Biomarkers in Retinitis Pigmentosa

Who this might be right for
Retinitis Pigmentosa
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 35
Not applicableStudy completedNCT01890187
What this trial is testing

Repeatability and Reproducibility of Cirrus HD-OCT Measurements of Illumination Areas Under the Retinal Pigment Epithelium

Who this might be right for
Advanced Dry AMD With Geographic Atrophy
Carl Zeiss Meditec, Inc. 85
Not applicableStudy completedNCT01272076
What this trial is testing

Cirrus HD-OCT Measurement of Area of Increased Light Penetration Under the Retinal Pigment Epithelium (RPE)

Who this might be right for
Age Related Macular DegenerationGeographic Atrophy
Carl Zeiss Meditec, Inc. 85
Not applicableUnknownNCT00403884
What this trial is testing

Selective RPE Laser Treatment (SRT) for Various Macular Diseases

Who this might be right for
Age-Related Macular DegenerationDiabetic MaculopathyCentral Serous Chorioretinopathy
University of Regensburg 60
Not applicableStudy completedNCT02051998
What this trial is testing

Directional Spread in Geographic Atrophy

Who this might be right for
Nonexudative Age-related Macular Degeneration
University Hospital, Bonn 130
Testing effectiveness (Phase 2)Looking for participantsNCT04339764
What this trial is testing

Autologous Transplantation of Induced Pluripotent Stem Cell-Derived Retinal Pigment Epithelium for Geographic Atrophy Associated With Age-Related Macular Degeneration

Who this might be right for
Dry Age-Related Macular DegenerationGeographic Atrophy
National Eye Institute (NEI) 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT02286089
What this trial is testing

Safety and Efficacy Study of OpRegen for Treatment of Advanced Dry-Form Age-Related Macular Degeneration

Who this might be right for
Age-Related Macular Degeneration
Hoffmann-La Roche 24
Not applicableLooking for participantsNCT07680244
What this trial is testing

(CIRRUS-2023-1) CLINICAL CLIN Assessment of PathFinder 1.0 on the CIRRUS 6000 and the CIRRUS 5000

Who this might be right for
Epiretinal MembraneDry Age Related Macular DegenerationMacular Abnormalities+7 more
Carl Zeiss Meditec-Dublin CoCe 400
Early research (Phase 1)Looking for participantsNCT07594236
What this trial is testing

Phase 1 Study of C.001 in Retinal Degeneration

Who this might be right for
Geographic AtrophyStargardt DiseaseRPE-mediated Maculopathy+1 more
Cellio Therapeutics Inc 15
Not applicableStudy completedNCT02332343
What this trial is testing

Sparing of the Fovea in Geographic Atrophy Progression

Who this might be right for
AtrophyGeographic AtrophyAge-related Macular Degeneration+1 more
University Hospital, Bonn 26
Not applicableStudy completedNCT01799564
What this trial is testing

Micropulse Laser for Geographic Atrophy

Who this might be right for
Geographic AtrophyAge-related Macular Degeneration
Institut de la Macula y la Retina 11
Testing effectiveness (Phase 2)Study completedNCT00306488
What this trial is testing

OT-551 Antioxidant Eye Drops to Treat Geographic Atrophy in Age-Related Macular Degeneration

Who this might be right for
Geographic AtrophyAge-Related Macular DegenerationAMD
National Institutes of Health Clinical Center (CC) 11